Policy

October 10th 2025

Explore the implications of the Most Favored Nation Order on US drug pricing reform and its potential impact on patient access and innovation.

October 9th 2025

UC Davis Health enhances patient care through a shared services center, ensuring continuity of care and optimizing pharmacy growth strategies.

October 7th 2025

Public health must address emotional and structural inequities, emphasizes Perry N. Halkitis, PhD, MS, MPH, dean of the Rutgers School of Public Health.

October 6th 2025

Today, Amgen announced the launch of AmgenNow, a direct-to-patient program offering evolocumab (Repatha) at nearly 60% below the current US list price.